When GLRX3 was downregulated using shRNA and siRNA in a pancreatic cancer cell line, c-Met and its downstream molecules such as PI3K and pAKT were decreased; however, c-Met knockdown did not affect GLRX3 expression. This evidence concerns the gene GLRX3 and familial pancreatic carcinoma.